Worldwide Facial Injectables Market Research Report

GURGAON, India - June 3, 2019 - PRLog -- Facial injectable are products that contain hyaluronic acid fillers, collagen fillers, and synthetic fillers for instance calcium hydroxyl apatite. The use of these products like hyaluronic acid enhances skin hydration, improves skin, and defends from Ultra Violet (UV) damage & has relatively low side effects. It helps in rejuvenating facial skin by raising scar depressions, reducing or eliminating wrinkles, and enhancing lips.

According to study, "Worldwide Facial Injectables Market Drivers, Opportunities, Trends, and Forecasts: 2017-2023" some of the major companies that are currently working in the worldwide facial injectables market are Advanced Dermatology, Allergan Plc, Merz Pharma GmbH & Co., Suneva Medical Inc., L.P., Fibrogen, Integra Lifesciences, Valeant Pharmaceuticals International Inc., Sanofi SA, ColBar LifeSciences Ltd., Ethicon, Merz Pharma GmbH & Co. KGaA, Tei BioSciences, Medytox Inc., Ankita Therapeutics Inc., Teoxane SA, Galderma S.A., KGaA, Nestle Skin Health (Galderma Pharma SA), Sinclair Pharma Plc, Ipsen S.A., Bloomage Biotechnology Corp. Ltd. All these key vendors are adopting partnerships and product launches policies in order to address the unmet aesthetic requirements thereby, offering physicians with new & better options.

Based on type, worldwide facial injectable market is segmented into dermal fillers or injectable implants and wrinkle relaxers. Dermal fillers include collagen, hyaluronic acid, calcium hydroxylapatite, fat injection, Polymethyl-methacrylate microspheres (PMMA), polylactic acid and others (polyalkylimide). Wrinkle relaxers include dysport, botox and xeomin. Based on product type, market is segmented into Restylane-Hyaluronic Acid-Based Filler, PREVELLE Silk-Hyaluronic Acid-Based Filler, Juvederm-Hyaluronic Acid-Based Filler, Belotero-Hyaluronic Acid-Based Filler, Hydrelle-Hyaluronic Acid-Based Filler, Evolence-Collagen-Based Fillers, Cosmoplast-Collagen-Based Fillers, Radiesse-Semi-Permanent Fillers, Sculptra-Semi-Permanent Fillers, BOTOX-OnabotulinumtoxinA, ArteFill-Permanent Fillers, Xeomin-IncobotulinumtoxinA, Dysport-AbobotulinumtoxinA, Myobloc-RimabotulinumtoxinB. Furthermore, the other applications include lip augmentation, lipoatrophy treatment, face lift, facial line correction and others (earlobe rejuvenation & chin augmentation). Additionally, based on end-users, market is segmented into beauty clinics, hospitals, dermatology research institutes and dermatology clinics.

The International Society of Aesthetic Plastic Surgery (ISAPS) is an association for board-specialized aesthetic plastic surgeons, dedicated to encouraged related to excellence in the field of aesthetic plastic surgery worldwide. The Society recommends symposia, instructional courses, and educational courses, while the members of ISAPS have entrance to the most advanced techniques such as dermal fillers and botulinum toxin. Furthermore, the American Academy of Facial Esthetics (AAFE) aims to give information about non-invasive and non-surgical facial injectable techniques to healthcare experts globally. AAFE is also devoted to providing the most excellent possible outcomes in areas of facial pain treatment and facial esthetics.

The worldwide facial injectable market is driven by the introduction of cost-effective facial injectables with the increase in aging population, growing awareness about facial injections, and rising aesthetic consciousness leading to increase in cosmetic procedures. Apart from profits, some of the major restraints leading to reimbursement policies supporting cosmetic procedures, followed by presence of counterfeit products & unregistered practitioners and side-effects of available products are impacting the market growth substantially. The worldwide facial market is witnessing the rise in trends in medical tourism and increase in demand for combination treatments etc.

North America being the leader in the global facial injectables market increasing the emphasis about physical appearance and increasing awareness on the advanced beauty treatments. In 2017, approximately 2 million women in U.S. have undergone an aesthetic injectable procedures, while approximately 17 million were considered to be aesthetic injectable cure, leading to growing demand for facial injectable.

For more information, click on the link below:

https://www.kenresearch.com/healthcare/pharmaceuticals/worldwide-facial-injectables/173263-91.html

Contact Us:

Ken Research

Ankur Gupta, Head Marketing & Communications

sales@kenresearch.com
+91 9015378249